产品详情
Targets
Target | Value |
---|---|
C-Raf-1(Y340D/Y341D) | IC50: 6.7nM |
B-Raf(V600E) | IC50: 13nM |
BRK | IC50: 130nM |
B-Raf | IC50: 160nM |
FRK | IC50: 1.3μM |
CSK | IC50: 1.5μM |
Src | IC50: 1.7μM |
FAK | IC50: 1.7μM |
FGFR | IC50: 1.9μM |
KDR | IC50: 2.3μM |
HGK | IC50: 2.8μM |
CSF-1R | IC50: 3.3μM |
AuroraA | IC50: 3.4μM |
In vitro (25°C) | DMSO | 81 mg/mL (195.73 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 2% DMSO+50% PEG 300+5% Tween 80+ddH2O | 4 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 24.17 mL | 120.83 mL | 241.66 mL |
0.5 mM | 4.83 mL | 24.17 mL | 48.33 mL |
1 mM | 2.42 mL | 12.08 mL | 24.17 mL |
5 mM | 0.48 mL | 2.42 mL | 4.83 mL |
*The above data is based on the productmolecular weight 413.8. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A10002 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 413.8 |
Formula | C17H14ClF2N3O3S |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 918505-84-7 |
Synonyms | PLX4720 |
SMILES | CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)Cl)F |
产品标签
Product Questions
Product Questions
LGX 818 (Encorafenib)
LGX 818 (Encorafenib)是一种Raf激酶抑制剂,具有潜在的抗肿瘤活性。
B-Raf-inhibitor 1
B-Raf inhibitor 1是有效的选择性B-Raf抑制剂,对A375增殖和A375 p-ERK的细胞IC50分别为0.31 uM和2 nM。
PF-04880594
PF-04880594是RAF抑制剂,BRAF/BRAFV599E和c-RAF的IC50值分别为0.19 nM/0.13 nM和0.39 nM。
RO5126766 (CH5126766)
RO5126766 (CH5126766)是对Raf和MEK丝裂原激活的蛋白激酶(MAPK)具有特异性的蛋白激酶抑制剂,具有潜在的抗肿…